BIS-F Stock Overview
Manufactures and distributes pharmaceutical supplies, medical devices, and equipment in Thailand.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Rewards
Risk Analysis
Bioscience Animal Health Public Company Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ฿6.00 |
52 Week High | ฿0 |
52 Week Low | ฿0 |
Beta | 0.59 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | 0% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
BIS-F | TH Healthcare | TH Market | |
---|---|---|---|
7D | 0% | -1.3% | 0.4% |
1Y | 0% | -2.7% | -9.9% |
Return vs Industry: BIS-F exceeded the TH Healthcare industry which returned -2.7% over the past year.
Return vs Market: BIS-F exceeded the TH Market which returned -9.9% over the past year.
Price Volatility
BIS-F volatility | |
---|---|
BIS-F Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 3.8% |
Market Average Movement | 4.3% |
10% most volatile stocks in TH Market | 9.3% |
10% least volatile stocks in TH Market | 2.3% |
Stable Share Price: BIS-F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BIS-F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | n/a | Dhanawat Khongjaroensombat | www.bis-group.com/en/our-subsidiaries/bioscience-animal-health |
Bioscience Animal Health Public Company Limited manufactures and distributes pharmaceutical supplies, medical devices, and equipment in Thailand. The company offers bioscience products, such as antibiotics, additives, injections, mold inhibitors, water-soluble products, vaccines, and Bismix B and SD series. It also provides products for livestock and pets, as well as trading services.
Bioscience Animal Health Public Company Limited Fundamentals Summary
BIS-F fundamental statistics | |
---|---|
Market cap | ฿1.04b |
Earnings (TTM) | ฿57.76m |
Revenue (TTM) | ฿2.46b |
18.1x
P/E Ratio0.4x
P/S RatioIs BIS-F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BIS-F income statement (TTM) | |
---|---|
Revenue | ฿2.46b |
Cost of Revenue | ฿2.10b |
Gross Profit | ฿360.58m |
Other Expenses | ฿302.83m |
Earnings | ฿57.76m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.18 |
Gross Margin | 14.63% |
Net Profit Margin | 2.34% |
Debt/Equity Ratio | 0% |
How did BIS-F perform over the long term?
See historical performance and comparison